A lipopeptide is a molecule which basically consists of lipids that are connected to a peptide; they are even able to self-assemble into different structures.
This ability allows for incredible versatility, giving lipopeptides the ability to be used in the creation of antibiotics, toll-like receptor agonists, antifungal and hemolytic activities; they can also interact with plasma membranes and display bactericidal activity.
SHARE:
Products sold on our website are designed for in vitro testing and lab experimentation exclusively.
All the products you see on the website are being sold in a lyophilized powder state (freeze-dried), in a sealed sterile vial; and should be reconstituted.
The product’s label clearly states the amount of product a vial contains; some products are offered in different variations.
The products we are selling come in a sealed vial but require additional lab equipment for proper testing.
Lipopeptide, the Palmitoyl-Gly-Gln-Pro-Arg sequence, is a palmitoylated IgG fragment, one of the major antibodies involved in immune response and inflammation. Modification, called palmitoylation, involves adding a molecule of palmitic acid to the peptide. The modification appears to enhance the capacity of the Lipopeptide to penetrate further into skin tissue models, specifically into corneal layers.
The included fat constituent (palmitic acid) likely aids in the simple transit of the peptide through the lipid-rich outer layers of skin, which increased overall effectiveness within experimental models.
Research has investigated the ability of peptide mix, including Lipopeptide (Pal-GQPR), to increase skin structure. In one experiment, echography tests were administered and found that this combination of peptides can reduce the thickness of the subepidermal low-echogenic band but increase its density.
This means that Lipopeptide may have the ability to improve skin texture and overall texture. Animal tests have also revealed that the peptide will strengthen the extracellular dermal matrix, which provides skin elasticity and firmness.
The efficacy of Lipopeptide was tested in a randomized controlled clinical trial (RCT) as a product blended with other peptides and actives. The peptide, along with other ingredients, such as retinyl palmitate and plant extracts, was assessed for its capacity to improve the appearance of photoaged cells.
Upon twelve days of the experiment, the peptide was noted to have induced the deposition of fibrillin-1 in the skin, a marker of skin repair compared to baseline levels. This was constructed with apparently observed effects of all-trans retinoic acid (RA), which has been described as a clinical standard for photoaged cells of the skin. The deposition of fibrillin-1 implies a potential structural alteration of skin but is insufficient to ensure the experiment's success.
In 6 months-RCT, the peptide appeared to improve the wrinkling of the skin compared to baseline. What’s more interesting, this potential improvement was further enhanced in 12 months. The vehicle formulation that did not have the active ingredients failed to exhibit similar results, which suggests that the active ingredients for the test product, for example, Lipopeptide, may be to blame for the effects.
Besides, the distribution of fibrillin-1 within skin biopsies from RCT was investigated in this study. Lipopeptide-treated skin appeared to possess a large amount of fibrillin-1 within the papillary dermis compared to the placebo group. This means that long-term therapies with Lipopeptide can induce a visible improvement in the photoaged skin.
Useful links
Our support team is at your service, ensuring customer satisfaction.
Our support team is at your service, ensuring customer satisfaction.
